Abstract
Current rhinitis treatment is unsatisfactory for many patients, possibly because monotherapy is employed, without regard to the major presenting symptom. Recognition of the impact of rhinitis on quality of life and on associated disorders such as asthma has led to the development of guidelines, use of which has been shown to improve symptom control and quality of life compared to unguided therapy. The role of antihistamines, topical corticosteroids and anti-leukotrienes is discussed.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pediatric Otorhinolaryngology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
